Medical transdermal patch

A transdermal patch and adhesive layer technology, applied in the field of medical materials, can solve the problems of adverse skin reactions, skin damage, irritation of the back skin, etc., to improve the transdermal ability, fast onset, and good therapeutic effect. Effect

Inactive Publication Date: 2019-10-22
湖南博隽生物医药有限公司
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, experiments have shown that the use of simple acrylic pressure-sensitive adhesives containing functional groups such as carboxyl groups or hydroxyl groups are all irritating to the skin on the back of New Zealand white rabbits, especially the addition of various chemical penetration enhancers in the prescription have different degrees of skin irritation. damage
And if the prescription contains excess sodium hydroxide, it can also cause adverse reactions to the patient's skin

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medical transdermal patch
  • Medical transdermal patch

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030]A medicinal transdermal patch, comprising a backing layer, an acrylic pressure-sensitive adhesive layer, a skeleton layer, an organic silicon pressure-sensitive adhesive layer and an anti-adhesive layer from top to bottom, wherein the The skeleton layer is made of the following raw materials in parts by weight: isobornyl acrylate / isopulegol / glycerin monooleate / polyethylene glycol monoallyl ether / 1-allyl-3-methyl chloride 40 parts of imidazole / 6-O-allyl-β-cyclodextrin copolymer, 8 parts of tobramycin, 4 parts of DL-aminocaprolactam amidated alginic acid, 8 parts of azone, 0.01 part of fusion protein, transdermal 1 part of functional Chinese herbal medicine extract.

[0031] The material of the backing layer is a polyurethane film; the material of the anti-adhesive layer is a polyester film whose surface is anti-adhesive treated with silicone oil.

[0032] The isobornyl acrylate / isopulegol / glycerol monooleate / polyethylene glycol monoallyl ether / 1-allyl-3-methyl imidazole ...

Embodiment 2

[0036] A pharmaceutical transdermal patch, comprising a polyester composite film backing layer, a polyacrylate pressure-sensitive adhesive layer, a skeleton layer, a polyurethane pressure-sensitive adhesive layer and a fluoropolymer coating from top to bottom The polyester release layer is characterized in that the skeleton layer is made of the following raw materials in parts by weight: isobornyl acrylate / isopulegol / glycerin monooleate / polyethylene glycol monoallyl ether / 43 parts of 1-allyl-3-methylimidazole chloride / 6-O-allyl-β-cyclodextrin copolymer, 9 parts of sinomenine, 4.5 parts of DL-aminocaprolactam amidated alginic acid, mint 9 parts of alcohol, 0.015 parts of fusion protein, and 1.2 parts of Chinese herbal medicine extract with transdermal function.

[0037] The isobornyl acrylate / isopulegol / glycerol monooleate / polyethylene glycol monoallyl ether / 1-allyl-3-methyl imidazole chloride / 6-O-allyl- The preparation method of β-cyclodextrin copolymer comprises the followi...

Embodiment 3

[0041] A pharmaceutical transdermal patch, which includes an ethylene vinyl acetate film backing layer, a polyacrylate pressure-sensitive adhesive layer, a skeleton layer, a polyurethane pressure-sensitive adhesive layer, and a silicone oil anti-adhesive layer from top to bottom. The treated polyester film anti-adhesive layer is characterized in that the skeleton layer is made of the following raw materials in parts by weight: isobornyl acrylate / isopulegol / glycerin monooleate / polyethylene glycol monoallyl 45 parts of base ether / 1-allyl-3-methyl imidazole chloride / 6-O-allyl-β-cyclodextrin copolymer, 10 parts of metformin hydrochloride, 5 parts of DL-aminocaprolactam amidated alginic acid , 10 parts of urea, 0.02 parts of fusion protein, and 1.5 parts of Chinese herbal medicine extract with transdermal function.

[0042] The isobornyl acrylate / isopulegol / glycerol monooleate / polyethylene glycol monoallyl ether / 1-allyl-3-methyl imidazole chloride / 6-O-allyl- The preparation method...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medical transdermal patch. The patch sequentially comprises a backing layer, a viscose layer I, a skeleton layer, a viscose layer II and an anti-viscose layer from top to bottom. The skeleton layer is characterized by being made from, by weight, 40-50 parts of a isoborneyl acrylate/isoimperhol/glycerin monooleate/polyethylene glycol monoallyl ether/1-allyl-3-methylimidazole chloride/ 6-O-allyl-beta-cyclodextrin copolymer, 8-12 parts of active ingredients, 4-6 parts of DL-aminocaprolactam amidated alginate, 8-12 parts of a penetration enhancer, 0.01-0.03 part of fusionprotein, and 1-2 parts of transdermal functional Chinese herbal extracts. The medical transdermal patch has an excellent transdermal effect, the air permeability is good, the storage stability is good, no irritation is caused to the skin, drug release can be effectively controlled, the patch takes effect rapidly and the treatment effect is good.

Description

technical field [0001] The invention relates to the technical field of medical materials, in particular to a medicinal transdermal patch. Background technique [0002] In recent years, with the development of science and technology, the gradual improvement of medical level, and the gradual deepening of people's understanding of transdermal drug delivery, it has become one of the main drug delivery methods generally accepted by people. The drug is administered in the form of application, so that the drug passes through each layer of the skin at a certain speed, and is absorbed by the capillary into the body circulation to produce a systemic or local therapeutic effect, avoiding the "first-pass effect" of the drug on the liver and the decomposition of the gastrointestinal tract, and improving the Therapeutic effect; it can maintain a relatively stable blood drug concentration, avoid peak and valley phenomena, and reduce side effects; it can prolong the administration time, red...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/70A61K47/14A61K47/10A61K47/22A61K47/40A61K47/36A61K47/42A61K47/69A61K47/46A61K31/702A61K31/485A61K31/155A61K31/196A61K36/54A61P17/00A61P17/18A61P17/16A61K31/125
CPCA61K9/7023A61K31/125A61K31/155A61K31/196A61K31/485A61K31/702A61K36/285A61K36/328A61K36/489A61K36/539A61K36/54A61K47/10A61K47/14A61K47/22A61K47/36A61K47/40A61K47/42A61K47/46A61K47/6951A61P17/00A61P17/16A61P17/18A61K2300/00
Inventor 朱水寿陈伟
Owner 湖南博隽生物医药有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products